SPL
Click for more information
4.40% 9.5¢ starpharma holdings limited

Ann: VivaGel BV US FDA Appeal Outcome, page-4

  1. col69
    15,564 Posts.
    lightbulb Created with Sketch. 5622
    clock Created with Sketch.
    19/02/24
    09:44
    Post #: 72477523
    What an absolute waste of money - could have undertaken multiple trials in the 5+ years and now they claim they aren't going to do any additional trials ..... well not Starpharma 'alone' any way ?   Does this mean they will seek a partner to undertake these trials in the USA  .... who knows but just another failure of the 17 year CEO Jackie Fairley by the looks

    How's that ITP upfront payment going @antibotter  ?

    upload_2024-2-19_9-41-35.png
    SPL Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch
right-arrow Created with Sketch.
NEWS The business of sport: Warren Tredrea's take on this week's news
right-arrow Created with Sketch.
PLS Pilbara blames low lithium prices for 89% drop in profit for FY24
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions
right-arrow Created with Sketch.
RDN Raiden gears up for exploration in final quarter of 2024
right-arrow Created with Sketch.
JAV Javelin increases the resource of Coogee in WA by 158%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢ 		Change
0.004(4.40%) 		Mkt cap ! $39.17M
Open High Low Value Volume
9.2¢ 9.6¢ 9.2¢ $81.30K 864.2K

Buyers (Bids)

No. Vol. Price($)
1 28056 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 1285 1
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.